HOME >> BIOLOGY >> NEWS
1st International Conference on Cell Therapy for Cardiovascular Disease

The First International Conference on Cell Therapy for Cardiovascular Diseases: A One Day Symposium will consist of a morning and an afternoon session. Presentations will focus on current data in both basic and clinical areas, and will be delivered in a format designed to promote discussion and debate.

During the morning session, local factors that serve to promote or interfere with cell survival will be discussed, followed by a detailed review of cell types under active investigation. This will be followed by a review of cell delivery strategies and methods for evaluating their effects. An open debate over lunch will follow. The afternoon session will consist of a comprehensive review of data from both completed and ongoing clinical trials for both acute and chronic myocardial disease, followed by a question-and-answer session.

The Symposium will bring together the leaders in the field of cardiac myogenesis. It is anticipated that many attendees will have preexisting knowledge of principles, experimental design, and results of completed studies in the field of cell therapy for cardiovascular diseases. A wide cross-section of members of basic and clinical researchers, from academic, industry, and regulatory communities will be in attendance.

Date:
Wednesday, June 16, 2004
8:00 a.m. to 5:00 p.m.

Location:
New York Academy of Medicine
1216 Fifth Avenue
Corner of Fifth Avenue and 103rd Street
New York, NY 10029
Tel: 212-822-7200

Symposium Director:

Warren Sherman, M.D.
Director of Medical Education, Cardiac Catheterization Laboratories
Associate Director, Cardiac Catheterization Laboratories
The Zena and Michael A. Wiener Cardiovascular Institute
The Mount Sinai Hospital, New York

Symposium Co-Directors:

Valentin Fuster, M.D., Ph.D.
Director, The Zena and Michael A. Wiener Cardiovascular Institute and The M
'"/>

Contact: Mount Sinai Press Office
NewsMedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
10-Jun-2004


Page: 1 2

Related biology news :

1. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
2. USAID, Conservation International & Starbucks launch Conservation Coffee Alliance in Central America
3. ConocoPhillips & Conservation International launch Biodiversity Action Plan in Venezuela
4. A room with a view for the International Space Station: Completion of the cupola observation module
5. International symposium on nutritional genomics
6. First International Scientific Conference on Childhood Leukaemia
7. International research conferences at the Villa Vigoni
8. Conservation International & SC Johnson invest in Ecuadors rainforest to offset climate impacts
9. STN International launches Derwent World Patents Index First View
10. Media invited to attend International Society For Heart & Lung Transplantation meeting April 21-24
11. International critical care doctors release first-ever guidelines for sepsis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... (PRWEB) , ... August 25, ... ... clinical-stage biotechnology company developing novel pharmaceuticals targeting mitochondria, in partnership with Essex ... enrolment in its pivotal U.S. Phase 3 VISTA-2 study of SkQ1 ophthalmic ...
(Date:8/21/2020)... ... August 18, 2020 , ... ... today announced that the U.S. Food and Drug Administration (FDA) has approved the ... SBI-101, for the treatment of severe COVID-19. Approval of this IND allows Sentien ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... Princeton, NJ, have entered into license agreements with Housey Pharma’s HMI subsidiary to ... Roche and J&J have annual Research and Development spending in excess of US ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... ... August 03, 2020 , ... Introducing Ardent Animal Health – MediVet Biologics rebrands ... , Known as MediVet Biologics since its formation in 2016, the company is ... Animal Health will build on its base of innovative therapies for osteoarthritis and cancer. ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... reliable, solid-state radar transmitter systems that can be configured to drive Klystrons, TWTs, ... controller that can drive one or two switches in a push-pull configuration; yielding ...
(Date:7/31/2020)... ... ... eSource has long been touted as the solution to high data management and monitoring ... did not take off as quickly as people initially expected, and where eSource is ... data electronically for clinical trials and then repurposing it for downstream analysis, at a ...
Breaking Biology Technology:
Cached News: